These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32822525)

  • 1. A batch-effect adjusted Simon's two-stage design for cancer vaccine clinical studies.
    Wang C; Wang Z; Rosner GL; Huh WK; Roden RBS; Bae S
    Biometrics; 2021 Sep; 77(3):1075-1088. PubMed ID: 32822525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified Simon's minimax and optimal two-stage designs for single-arm phase II cancer clinical trials.
    Kim J; Schell MJ
    Oncotarget; 2019 Jul; 10(42):4255-4261. PubMed ID: 31303960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical inference for extended or shortened phase II studies based on Simon's two-stage designs.
    Zhao J; Yu M; Feng XP
    BMC Med Res Methodol; 2015 Jun; 15():48. PubMed ID: 26048655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When is a two-stage single-arm trial efficient? An evaluation of the impact of outcome delay.
    Mukherjee A; Wason JMS; Grayling MJ
    Eur J Cancer; 2022 May; 166():270-278. PubMed ID: 35344852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive sequential design for phase II single-arm oncology trials: an expansion of Simon's design.
    Gao P; Zhang W
    J Biopharm Stat; 2024 Apr; ():1-15. PubMed ID: 38619921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal futility stopping boundaries for binary endpoints.
    Freitag MM; Li X; Rauch G
    BMC Med Res Methodol; 2024 Mar; 24(1):80. PubMed ID: 38539108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials.
    Jin H; Wei Z
    Contemp Clin Trials; 2012 Nov; 33(6):1255-60. PubMed ID: 22772088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adapting Simon's Two-Stage Design for Efficient Screening of Filovirus Vaccines in Non-Human Primates.
    Niemuth NA; Sabourin CL; Ward LA
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 36016104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal adaptive two-stage designs for early phase II clinical trials.
    Shan G; Wilding GE; Hutson AD; Gerstenberger S
    Stat Med; 2016 Apr; 35(8):1257-66. PubMed ID: 26526165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal inference for Simon's two-stage design with over or under enrollment at the second stage.
    Shan G; Chen JJ
    Commun Stat Simul Comput; 2018; 47(4):1157-1167. PubMed ID: 31097866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian enhancement two-stage design for single-arm phase II clinical trials with binary and time-to-event endpoints.
    Shi H; Yin G
    Biometrics; 2018 Sep; 74(3):1055-1064. PubMed ID: 29466612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-stage optimal designs with survival endpoint when the follow-up time is restricted.
    Shan G; Zhang H
    BMC Med Res Methodol; 2019 Apr; 19(1):74. PubMed ID: 30943896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimax and admissible adaptive two-stage designs in phase II clinical trials.
    Shan G; Zhang H; Jiang T
    BMC Med Res Methodol; 2016 Aug; 16():90. PubMed ID: 27485595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proper inference from Simon's two-stage designs.
    Koyama T; Chen H
    Stat Med; 2008 Jul; 27(16):3145-54. PubMed ID: 17960777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design.
    Sampayo-Cordero M; Miguel-Huguet B; Pérez-García J; Páez D; Guerrero-Zotano ÁL; Garde-Noguera J; Aguirre E; Holgado E; López-Miranda E; Huang X; Malfettone A; Llombart-Cussac A; Cortés J
    Contemp Clin Trials Commun; 2020 Dec; 20():100678. PubMed ID: 33336109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian enhancement two-stage design with error control for phase II clinical trials.
    Jin H; Yin G
    Stat Med; 2020 Dec; 39(29):4452-4465. PubMed ID: 32854163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simon's bleedings: a possible mechanism of appearance and forensic importance--a prospective autopsy study.
    Nikolić S; Zivković V; Juković F; Babić D; Stanojkovski G
    Int J Legal Med; 2009 Jul; 123(4):293-7. PubMed ID: 19148663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stochastically curtailed phase II clinical trials.
    Ayanlowo AO; Redden DT
    Stat Med; 2007 Mar; 26(7):1462-72. PubMed ID: 16900560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to handling data when a phase II trial deviates from the pre-specified Simon's two-stage design.
    Wu Y; Shih WJ
    Stat Med; 2008 Dec; 27(29):6190-208. PubMed ID: 18800338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exact p-values for Simon's two-stage designs in clinical trials.
    Shan G; Zhang H; Jiang T; Peterson H; Young D; Ma C
    Stat Biosci; 2016; 8(2):351-357. PubMed ID: 28003856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.